Thomas A. Bradley
Thomas A. Bradley's purchase track record
How the stock did after each of Thomas A. Bradley's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/9/2024 | PLMR | $89K | +11.3% | +22.3% | +12.8% |
| 5/7/2024 | PLMR | $84K | +9.3% | +6.1% | +11.5% |
| 3/5/2024 | PLMR | $111K | +15.7% | +33.3% | +8.9% |
| 11/9/2022 | HMN | $96K | -4.1% | -9.1% | +10.4% |
| 5/11/2022 | HMN | $190K | -3.2% | +1.4% | -4.7% |
| 11/10/2021 | HMN | $101K | +2.5% | -6.1% | -15.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Palomar Holdings Gets AM Best Rating Affirmation and JPMorgan Target Cut. AM Best affirmed the credit ratings for Palomar Holdings and its member companies, reinforcing the firm's financial stability. Concurrently, JPMorgan maintained its Overweight rating but lowered its price target to $156. These updates provide a neutral backdrop for the stock, which is currently trading near its 52-week high.
Transaction History
| HMN | ▼ Sell | Open Market | 5,000 | $259K | 8/12/2026 | View on chart |
| PLMR | ▲ Buy | Grant | 1,304 | $0 | 5/21/2026 | View on chart |
| HMN | ▲ Buy | Grant | 2,780 | $130K | 5/20/2026 | View on chart |
| PLMR | ▲ Buy | Grant | 715 | $0 | 5/22/2025 | View on chart |
| HMN | ▲ Buy | Grant | 3,135 | $130K | 5/14/2025 | View on chart |
| PLMR | ▲ Buy | Option Exercise | 1,331 | $0 | 2/28/2025 | View on chart |
| PLMR | ▲ Buy | Open Market | 1,000 | $89K | 8/9/2024 | View on chart |
| PLMR | ▲ Buy | Grant | 1,224 | $0 | 5/23/2024 | View on chart |
| HMN | ▲ Buy | Grant | 3,807 | $130K | 5/22/2024 | View on chart |
| PLMR | ▲ Buy | Open Market | 1,000 | $84K | 5/7/2024 | View on chart |
| PLMR | ▲ Buy | Open Market | 1,500 | $111K | 3/5/2024 | View on chart |
| HMN | ▲ Buy | Grant | 3,657 | $115K | 5/24/2023 | View on chart |
| HMN | ▲ Buy | Open Market | 2,500 | $96K | 11/9/2022 | View on chart |
| HMN | ▲ Buy | Grant | 2,911 | $0 | 5/25/2022 | View on chart |
| HMN | ▲ Buy | Open Market | 5,000 | $190K | 5/11/2022 | View on chart |
| HMN | ▲ Buy | Open Market | 2,500 | $101K | 11/10/2021 | View on chart |
| HMN | ▲ Buy | Grant | 2,705 | $0 | 11/5/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Horace Mann Q2 Earnings Call and Insurance Sector Outlook
Horace Mann Educators released its Q2 2026 earnings conference call transcript, providing details on recent performance. The company is also featured in industry outlooks and lists of multiline insurance stocks, highlighting its role in the broader sector. While peer Aflac announced new AI tools, Horace Mann’s news focuses on its own financial results and market position within the insurance industry.
Horace Mann Q2 Earnings Call and Insurance Sector Outlook. Horace Mann Educators released its Q2 2026 earnings conference call transcript, providing details on recent performance. The company is also featured in industry outlooks and lists of multiline insurance stocks, highlighting its role in the broader sector. While peer Aflac announced new AI tools, Horace Mann’s news focuses on its own financial results and market position within the insurance industry.